Streetbeat News

Stock Prices

KRTX

Over the past 3 months, 8 Wall Street analysts have provided ratings for Karuna Therapeutics (NASDAQ:KRTX), with an average price target of $275.5, which is higher than the current price of $179.73. All 8 analysts are bullish or somewhat bullish, with no indifferent, somewhat bearish, or bearish ratings. The current average price target has decreased by 1.69% from the previous target of $280.25.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 12:00 pm

CAT

Over the past 3 months, 4 Wall Street analysts have provided ratings on Caterpillar (NYSE:CAT), with an average price target of $284.75, representing an implied upside from the current price of $252.49. The consensus includes 2 bullish, 1 somewhat bullish, and 1 indifferent rating. This average price target is a 6.33% decrease from the previous target of $304.00. Analysts rate stocks to predict performance, and these ratings are updated quarterly.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 12:00 pm

WBX

Wallbox N.V. (NYSE:WBX) has partnered with Atlante, a company of NHOA Group, to develop a network of EV fast-charging stations across Italy, France, Spain, and Portugal. The collaboration aims to install 5,000 charging points by 2025 and 35,000 by 2030, powered by renewable energy. Atlante will use Wallbox's Supernova chargers for the network, which will be located along major transportation routes in compliance with new EU legislation. Wallbox's stock is down 5.96% in premarket trading.

Portfolio Pulse from Vandana Singh

November 20, 2023 | 11:51 am

ARVN

Guggenheim analyst Michael Schmitz has upgraded Arvinas (NASDAQ:ARVN) from Neutral to Buy and set a price target of $40 for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 11:49 am

ENLT

Enlight Renewable Energy (ENLT) reported Q3 earnings of $0.45 per share, surpassing the $0.10 estimate by 350%. However, their sales of $58.32M fell short of the expected $65.70M by 11.23%.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 11:47 am

VALE

B of A Securities analyst Caio Ribeiro has upgraded Vale (NYSE:VALE) from Neutral to Buy and set a price target of $20.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 11:46 am

ASA

EML

PRGO

Insiders at Eastern Company (EML), ASA Gold and Precious Metals (ASA), and Perrigo Company (PRGO) have made significant stock purchases. EML's Director acquired 5,000 shares, ASA's 10% owner bought 135,281 shares, and PRGO's EVP and Chief Scientific Officer purchased 2,040 shares. These transactions can signal confidence in the companies' prospects, potentially indicating investment opportunities.

Portfolio Pulse from Lisa Levin

November 20, 2023 | 11:40 am

ATHE

Shares of Alterity Therapeutics have been halted in anticipation of an announcement regarding a capital raise. The company had previously indicated on Sunday that it would be disclosing news related to raising capital.

Portfolio Pulse from Charles Gross

November 20, 2023 | 11:36 am

MSFT

NIO

YPF

In Monday's pre-market session, several stocks are showing significant gains. YPF Sociedad Anónima, Pampa Energía S.A., and Transportadora de Gas del Sur S.A. are among the top gainers, with increases of over 12%. Other notable gainers include Grupo Financiero Galicia S.A., Central Puerto S.A., Telecom Argentina S.A., Loma Negra Compañía, and Banco BBVA Argentina S.A. HireRight Holdings Corporation and NIO Inc. also saw substantial pre-market increases. Microsoft Corporation's pre-market gain is attributed to the hiring of OpenAI co-founders to lead a new AI research team.

Portfolio Pulse from Lisa Levin

November 20, 2023 | 11:25 am

SWTX

HC Wainwright & Co. analyst Robert Burns has maintained a Buy rating on SpringWorks Therapeutics (NASDAQ:SWTX) but reduced the price target from $58 to $52.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 11:22 am